Which of the following is NOT a hormone therapy for prostate cancer?

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

Which of the following is NOT a hormone therapy for prostate cancer?

Explanation:
Prostate cancer growth is driven by androgens, so therapies that reduce androgen production or block its effect are considered hormone therapies. Androgen deprivation therapy directly targets this axis by lowering testosterone or blocking its action. Anastrozole, on the other hand, is an aromatase inhibitor that lowers estrogen levels. While this is a hormonal mechanism, it is not a standard approach for prostate cancer, because estrogen suppression is not the main or proven strategy to control PCa growth. Chemotherapy and radiotherapy do not work by altering hormone signaling; they treat cancer through cytotoxic effects or localized tissue destruction. Therefore, Anastrozole is not used as a hormone therapy for prostate cancer.

Prostate cancer growth is driven by androgens, so therapies that reduce androgen production or block its effect are considered hormone therapies. Androgen deprivation therapy directly targets this axis by lowering testosterone or blocking its action. Anastrozole, on the other hand, is an aromatase inhibitor that lowers estrogen levels. While this is a hormonal mechanism, it is not a standard approach for prostate cancer, because estrogen suppression is not the main or proven strategy to control PCa growth. Chemotherapy and radiotherapy do not work by altering hormone signaling; they treat cancer through cytotoxic effects or localized tissue destruction. Therefore, Anastrozole is not used as a hormone therapy for prostate cancer.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy